Larson Financial Group »

Phathom Pharmaceuticals shares owned by Larson Financial Group

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.6k 647 11.77
2025-06-30 $6.2k 647 9.59
2025-03-31 $4.1k 647 6.27
2024-12-31 $6.5k 797 8.12
2024-09-30 $12k 647 18.08

More positions owned by Larson Financial Group

Spdr Series Trust Portfolio S&p500 (SPLG)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Capital Group Global Equity SHS (CGGE)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Broadcom (AVGO)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)

View all positions for Larson Financial Group

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Millennium Management
Invesco
Carlyle
BlackRock
Vanguard Group
Ensign Peak Advisors
NEA Management Company
683 Capital Management
Daniel D. Thurber
Catalys Pacific
Jennifer Ranahan
Catalio Capital Management
Geode Capital Management

View all funds holding Phathom Pharmaceuticals